CHTI BIO MEN : revenue, balance sheet and financial ratios

CHTI BIO MEN is a French company founded 9 years ago, specialized in the sector Activités des sociétés holding. Based in VILLENEUVE-D'ASCQ (59650), this company of category PME shows in 2021 a revenue of 250 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - CHTI BIO MEN (SIREN 829471697)
Indicator 2023 2021 2020 2019 2018
Revenue N/C 250 064 € 281 346 € 266 834 € 218 507 €
Net income 165 657 € 86 292 € 227 852 € 190 206 € 139 828 €
EBITDA N/C 2 936 € 49 292 € 13 763 € -8 747 €
Net margin N/C 34.5% 81.0% 71.3% 64.0%

Revenue and income statement

In 2023, CHTI BIO MEN generates positive net income of 166 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2023: 140 k€ -> 166 k€.

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

165 657 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 45%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 67%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

44.597%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

67.351%

Solvency indicators evolution
CHTI BIO MEN

Sector positioning

Debt ratio
44.6 2023
2020
2021
2023
Q1: 0.03
Med: 10.87
Q3: 70.22
Average -11 pts over 3 years

In 2023, the debt ratio of CHTI BIO MEN (44.60) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
67.35% 2023
2020
2021
2023
Q1: 17.2%
Med: 61.39%
Q3: 90.77%
Good +15 pts over 3 years

In 2023, the financial autonomy of CHTI BIO MEN (67.3%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
11.59 years 2021
2020
2021
Q1: -0.0 years
Med: 0.11 years
Q3: 3.68 years
Average

In 2021, the repayment capacity of CHTI BIO MEN (11.59) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 337.46. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

337.465

Liquidity indicators evolution
CHTI BIO MEN

Sector positioning

Liquidity ratio
337.46 2023
2020
2021
2023
Q1: 126.86
Med: 619.0
Q3: 3548.33
Average -17 pts over 3 years

In 2023, the liquidity ratio of CHTI BIO MEN (337.46) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
5876.33x 2021
2020
2021
Q1: -44.79x
Med: 0.0x
Q3: 0.0x
Excellent

In 2021, the interest coverage of CHTI BIO MEN (5876.3x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2023) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2023) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2023) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2023) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
CHTI BIO MEN

Positioning of CHTI BIO MEN in its sector

Comparison with sector Activités des sociétés holding

Valuation estimate

Based on 63 transactions of similar company sales in 2023, the value of CHTI BIO MEN is estimated at 1 545 219 € (range 281 683€ - 2 292 971€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2023
63 tx
281k€ 1545k€ 2292k€
1 545 219 € Range: 281 683€ - 2 292 971€
NAF 5 année 2023

Valuation method used

Net Income Multiple
165 657 € × 9.3x = 1 545 219 €
Range: 281 684€ - 2 292 972€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 63 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Activités des sociétés holding)

Compare CHTI BIO MEN with other companies in the same sector:

Frequently asked questions about CHTI BIO MEN

What is the revenue of CHTI BIO MEN ?

The revenue of CHTI BIO MEN in 2021 is 250 k€.

Is CHTI BIO MEN profitable?

Yes, CHTI BIO MEN generated a net profit of 166 k€ in 2023.

Where is the headquarters of CHTI BIO MEN ?

The headquarters of CHTI BIO MEN is located in VILLENEUVE-D'ASCQ (59650), in the department Nord.

Where to find the tax return of CHTI BIO MEN ?

The tax return of CHTI BIO MEN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does CHTI BIO MEN operate?

CHTI BIO MEN operates in the sector Activités des sociétés holding (NAF code 64.20Z). See the 'Sector positioning' section above to compare the company with its competitors.